Patients with a BMI of 30 kg/m or greater who are considering GLP-1 therapy should schedule a visit with a board-certified endocrinologist or obesity medicine specialist, request baseline metabolic labs (HbA1c, fasting lipids, hepatic function panel), and discuss a 12-month treatment plan that includes dietary modification and physical activity alongside pharmacotherapy 7
Monthly: Progress photos (front, side, back, in same lighting and clothing)
This means that insulin is only released when blood glucose levels are elevated, thereby reducing the risk of hypoglycemia, a common concern with other diabetes medications
"Novo Nordisk's strong legacy in obesity care and decades of scientific research and innovation have brought us to this moment
Mozaffarian D
Faecal occult blood test : a lab test used to detect hidden blood in stool